Standard Testing Method Peptide Powder for Consistent Research Material Quality Control

Name: Standard Testing Method Peptide Powder for Consistent Research Material Quality Control
Brand: Beijing Lingyan Biotechnology Co., Ltd.
SKU: 1988470821

Beijing, ChinaBeijing Lingyan Biotechnology Co., Ltd.

US$5.00-35.00

1 Box

Product profile

Customization

Available

Storage Method

Normal

Extraction Process

Research Use

Model NO.

peptide

Application

Research Use

State

Powder

Extract Source

Pig

Storge

Normal

Transport Package

Customized

Specification

provide tailored package on request

Trademark

LingYan

Origin

China

HS Code

2933360000

Production Capacity

500000

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceFast DeliveryLow MOQ

Beijing Lingyan Biotechnology Co., Ltd.

Beijing, China

CertifiedBusiness Type: Trading Company CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc.Export Year: 2025-06-03Nearest Port: HongKongAverage Response Time: ≤7.28hTerms of Payment: T/T, LC

AI-Powered supplier vetting

SummaryThe supplier specializes in flexible production models supporting biotechnology, pharmaceutical, and life sciences industries. They provide comprehensive manufacturing services, from small-scale research to large-scale production. However, the supplier lacks ODM and OEM services for well-known brands and international presence. Despite having clear procedures for quality control and customer complaint handling, there is no evidence of financial activity, innovation, or overseas service capability.

Supplier typeThe supplier is involved in the biotechnology, pharmaceutical, and life science industries, offering OEM/ODM production and custom technical services.

After-Sales capabilityThe supplier has clear procedures and records for handling customer complaints and quality control, indicating a structured approach to after-sales service.

Financial creditThe supplier shows no operating revenue, profit, or financial activity over the last three years, indicating a potential lack of financial credibility.

R&D capabilityThere is no evidence of innovation capability as the supplier has not introduced new products or SDK availability in the past year.

Production capacityThe supplier offers comprehensive production capabilities, including recombinant protein expression, gene cloning, and large-scale manufacturing.

Customization capabilityThe supplier provides full customization services from designs and samples, reflecting strong customization capabilities.